Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.

Journal of medical genetics - 1 Jul 2012

Pelttari Liisa M, Kiiski Johanna, Nurminen Riikka, Kallioniemi Anne, Schleutker Johanna, Gylfe Alexandra, Aaltonen Lauri A, Leminen Arto, Heikkilä Päivi, Blomqvist Carl, Bützow Ralf, Aittomäki Kristiina, Nevanlinna Heli

Abstract excerpt

BACKGROUND: RAD51D and RAD54L are involved in homologous recombination, and rare mutations in RAD51D were recently found in breast-ovarian cancer families. This study investigated RAD51D and RAD54L for mutations in breast and ovarian cancer patients in the Finnish population. METHODS: The study s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to DNA Helicases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Finland

Share to Founder Effect

Share to Homologous Recombination

Share to Nuclear Proteins

Share to Ovarian Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 22652533
DOI: 10.1136/jmedgenet-2012-100852
PMCID: PMC5426530

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22652533-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.PMID 22652533Read ↗

Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer.Semantic proximity Read ↗

A decade of RAD51C/D: Germline pathogenic variants and their phenotypic landscapeSemantic proximity Read ↗

Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.Semantic proximity Read ↗

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.Semantic proximity Read ↗

RAD51C is a susceptibility gene for ovarian cancer.Semantic proximity Read ↗

A decade of RAD51C and RAD51D germline variants in cancer.Semantic proximity Read ↗

Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic.Semantic proximity Read ↗

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patientsSemantic proximity Read ↗

Germline mutations in RAD51D confer susceptibility to ovarian cancer.Semantic proximity Read ↗

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.Semantic proximity Read ↗

Genetic testing for RAD51C mutations: in the clinic and community.Semantic proximity Read ↗

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique PopulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.